Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ambry Genetics Partners RainDance For Diagnostics, Genomics Services
Researchers can utilize the RDT 1000 and Ambry Genetics next generation services to either reduce study time, or to improve study quality by running more samples in the
Researchers can utilize the RDT 1000 and Ambry Genetics next generation services to either reduce study time, or to improve study quality by running more samples in the
With new diagnostic genetic markers like KIF6 and LPA, accessing stored DNA eliminates the need to collect a new sample and facilitates return of potentially critical medical information
Reliv said that a clinical study conducted at Gabriele D’Annunzio University in Chieti-Pescara, Italy and published in the journal Phytotherapy Research found that GlucAffect reduces blood glucose levels
The newly developed IDD discovery platform enables the in silico identification of peptide sequences that are predicted to have the potential to penetrate the cell membrane. The new
The approval for both Vit Kit-Freeze and Vit Kit-Thaw allows users greater flexibility to vitrify specimens depending on the in-vitro fertilization (IVF) laboratory’s protocol and their patients’ needs.
Regulus said that the patent is owned by Stanford University and licensed exclusively to the company. miR-181a has been shown to regulate the response of immune cells, such
The operating loss was $6.6m compared to operating income of $3.9m in the same period of 2009. First quarter adjusted EBITDA was $9.3m, a decrease of $12.8m in
Niacin is a type of B vitamin that aids in the function of the digestive system, skin, nerves and heart health. The adult body needs at least 14-16mg
Microfluidics claimed that the LV1, which operates with the same fixed-geometry interaction chamber technology of larger volume machines, brings better capabilities for uniform particle size reduction and cell
Prosonix claimed that the technology, which was made commercially available this month, uses a highly specialised new variant of the company’s sonocrystallisation technique to make active pharmaceutical ingredient